CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 4,078 enrolled
Drug / intervention
Telepharmacist interventionbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02512276
NCT02512276N/ACompleted
CompareCT.gov

The Study of a Tele-pharmacy Intervention for Chronic Diseases to Improve Treatment Adherence (STIC2IT)

Brigham and Women's Hospital·interventional·Posted Jul 30, 2015·Updated Jun 6, 2019

In Brief

A clinical study evaluating Telepharmacist intervention for Hyperlipidemia and 2 related conditions. Completed, enrolled 4,078 participants across 1 site.

Detailed Summary

The purpose of this cluster randomized controlled trial is to evaluate whether a novel tele-pharmacist-based intervention for patients with hyperlipidemia, hypertension, and diabetes improves medication adherence, disease control, and patients' understanding of their treatment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHyperlipidemia, Diabetes, Hypertension
CountriesUnited States
CollaboratorsHarvard Vanguard Medical Associates

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJul 30, 2015
Enrollment StartAug 1, 2015
Primary CompletionAug 1, 2017
Study CompletionOct 1, 2017
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 10.9 years ago

Interventions

Telepharmacist interventionbehavioral

The intervention consists of a brief telephonic consultation with a clinical pharmacist using behavioral interviewing techniques tailored to patient's level of health activation and progress reports of medication-taking and disease control. Based on the barriers identified during the initial telephone consultation, patients will be offered more intensive support including reminder and motivational text-messages, video visits and pillboxes.